New NUTRITION Research Available. Click Here to Access Article(s): https://t.co/ZxlqfSQyiu
43 followers
13,201 followers
2,104 followers
Ripretinib in combination with tyrosine kinase inhibitor as a late-line treatment option for refractory gastrointes… https://t.co/OlszEOy4WE https://t.co/CM6uuHRvUE
5,789 followers
New Research: Ripretinib in combination with tyrosine kinase inhibitor as a late-line treatment option for refractory gastrointestinal stromal tumors: two case reports and literature review #pharmacology https://t.co/xHyE1Ce0SM